Up-regulation of P-glycoprotein expression in small intestine under chronic serotonin-depleted conditions in rats. 2005

Hideo Hiraoka, and Naoji Kimura, and Yumiko Furukawa, and Ken-ichi Ogawara, and Toshikiro Kimura, and Kazutaka Higaki
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University, 1-1-1 Tsushimanaka, Okayama 700-8530, Japan.

To investigate the role of serotonin (5-HT), an important neurotransmitter and hormone/paracrine agent in the small intestine, in the transport activity of P-glycoprotein (P-gp), the intestinal transport of quinidine, a P-gp substrate, was examined in 5-HT-depleted rats prepared by intraperitoneal administration of p-chlorophenylalanine, a specific inhibitor of tryptophan hydroxylase in 5-HT biosynthesis. In the in vitro transport study, quinidine transport across rat jejunum was significantly enhanced in both the secretory and absorptive directions under 5-HT-depleted conditions, although the secretory transport was still predominant. The electrophysiological study suggested that the quinidine transport via passive diffusion was enhanced presumably through a paracellular route. This might be due to looser tight junctions under 5-HT-depleted conditions. The voltage-clamp technique clearly indicated that the secretory transport of quinidine through the transcellular pathway was also enhanced by the depletion of 5-HT. Furthermore, 5-HT depletion increased verapamil-sensitive secretory transport of quinidine in rat jejunum. These results indicate that the secretory transport of quinidine via P-gp was significantly enhanced under 5-HT-depleted conditions. The level of ATP, an energy source for functioning P-gp, wet weight of jejunum, and total protein level in rat jejunal mucosa were not changed by 5-HT depletion, but the expression of P-gp in the brush-border membrane of rat jejunum was significantly induced, which is partly responsible for the enhancement of P-gp activity under the 5-HT-depleted condition.

UI MeSH Term Description Entries
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D007421 Intestine, Small The portion of the GASTROINTESTINAL TRACT between the PYLORUS of the STOMACH and the ILEOCECAL VALVE of the LARGE INTESTINE. It is divisible into three portions: the DUODENUM, the JEJUNUM, and the ILEUM. Small Intestine,Intestines, Small,Small Intestines
D007583 Jejunum The middle portion of the SMALL INTESTINE, between DUODENUM and ILEUM. It represents about 2/5 of the remaining portion of the small intestine below duodenum. Jejunums
D008297 Male Males
D008871 Microvilli Minute projections of cell membranes which greatly increase the surface area of the cell. Brush Border,Striated Border,Border, Brush,Border, Striated,Borders, Brush,Borders, Striated,Brush Borders,Microvillus,Striated Borders
D011802 Quinidine An optical isomer of quinine, extracted from the bark of the CHINCHONA tree and similar plant species. This alkaloid dampens the excitability of cardiac and skeletal muscles by blocking sodium and potassium currents across cellular membranes. It prolongs cellular ACTION POTENTIALS, and decreases automaticity. Quinidine also blocks muscarinic and alpha-adrenergic neurotransmission. Adaquin,Apo-Quinidine,Chinidin,Quincardine,Quinidex,Quinidine Sulfate,Quinora,Apo Quinidine,Sulfate, Quinidine
D000255 Adenosine Triphosphate An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter. ATP,Adenosine Triphosphate, Calcium Salt,Adenosine Triphosphate, Chromium Salt,Adenosine Triphosphate, Magnesium Salt,Adenosine Triphosphate, Manganese Salt,Adenylpyrophosphate,CaATP,CrATP,Manganese Adenosine Triphosphate,MgATP,MnATP,ATP-MgCl2,Adenosine Triphosphate, Chromium Ammonium Salt,Adenosine Triphosphate, Magnesium Chloride,Atriphos,Chromium Adenosine Triphosphate,Cr(H2O)4 ATP,Magnesium Adenosine Triphosphate,Striadyne,ATP MgCl2
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic
D012701 Serotonin A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator. 5-HT,5-Hydroxytryptamine,3-(2-Aminoethyl)-1H-indol-5-ol,Enteramine,Hippophaine,Hydroxytryptamine,5 Hydroxytryptamine

Related Publications

Hideo Hiraoka, and Naoji Kimura, and Yumiko Furukawa, and Ken-ichi Ogawara, and Toshikiro Kimura, and Kazutaka Higaki
January 2000, Digestion,
Hideo Hiraoka, and Naoji Kimura, and Yumiko Furukawa, and Ken-ichi Ogawara, and Toshikiro Kimura, and Kazutaka Higaki
January 1996, Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994),
Hideo Hiraoka, and Naoji Kimura, and Yumiko Furukawa, and Ken-ichi Ogawara, and Toshikiro Kimura, and Kazutaka Higaki
December 2013, Journal of veterinary pharmacology and therapeutics,
Hideo Hiraoka, and Naoji Kimura, and Yumiko Furukawa, and Ken-ichi Ogawara, and Toshikiro Kimura, and Kazutaka Higaki
February 2007, Experimental eye research,
Hideo Hiraoka, and Naoji Kimura, and Yumiko Furukawa, and Ken-ichi Ogawara, and Toshikiro Kimura, and Kazutaka Higaki
January 2011, Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology,
Hideo Hiraoka, and Naoji Kimura, and Yumiko Furukawa, and Ken-ichi Ogawara, and Toshikiro Kimura, and Kazutaka Higaki
August 2013, Journal of pharmaceutical sciences,
Hideo Hiraoka, and Naoji Kimura, and Yumiko Furukawa, and Ken-ichi Ogawara, and Toshikiro Kimura, and Kazutaka Higaki
January 2013, Biological & pharmaceutical bulletin,
Hideo Hiraoka, and Naoji Kimura, and Yumiko Furukawa, and Ken-ichi Ogawara, and Toshikiro Kimura, and Kazutaka Higaki
January 2006, Redox report : communications in free radical research,
Hideo Hiraoka, and Naoji Kimura, and Yumiko Furukawa, and Ken-ichi Ogawara, and Toshikiro Kimura, and Kazutaka Higaki
May 1997, European journal of biochemistry,
Hideo Hiraoka, and Naoji Kimura, and Yumiko Furukawa, and Ken-ichi Ogawara, and Toshikiro Kimura, and Kazutaka Higaki
July 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Copied contents to your clipboard!